SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Cantel Medical Corp (NYSE – CMD)

BALA CYNWYD – January 12, 2021 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cantel Medical Corp (“Cantel” or the “Company”) (NYSE – CMD) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to be acquired by STERIS plc (NYSE – STE) (“STERIS”). Under the terms of the agreement, Cantel shareholders will receive only $16.93 in cash and 0.33787 shares of STERIS common stock for each share of Cantel they own, implying a deal consideration of $84.66 per Cantel common share, based on STERIS’s closing share price of $200.46 on January 11, 2021.

The investigation concerns whether the Cantel Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether STERIS is paying too little for the Company. For example, at least one wall street analyst has set a price target of $100 per share for Cantel stock.

If you own shares of Cantel stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, or call toll free 855-576-4847.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.